Skip to content

JACS JACS Offering Costs Charged To Additional Paid In Capital

Offering Costs Charged To Additional Paid In Capital at other companies

Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
$0-100%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$1.7M
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$0-100%
MidCap Financial Investment Corporation logo
MidCap Financial Investment CorporationMFIC
$300K
CEP
Cantor Equity Partners II, Inc. Class A Ordinary ShareCEPT
$5.3M+19,713%
CMS
CMS EnergyCMS
$6.67B+11.6%

Other financials

Income statement

See full
Operating income-$168.3K+18.4%
Net income$2.0M-11.6%
EPS (diluted)$0.07-12.5%

Balance sheet

See full
Cash & equivalents$393.5K-48.0%
Total equity$52.5K-91.0%
Total assets$245.2M+3.8%

Cash flow

See full
Operating cash flow-$128.3K+33.7%

Valuation

See full
Market cap$314.69M+3.3%
P/E35.5×

Returns & leverage

See full
Return on equity2,785.2%
Current ratio1.1×-1.2×

Where this comes from

Reported directly by JACS in its filing.

Tagged under the XBRL concept jacs:OfferingCostsChargedToAdditionalPaidInCapital.

The official record: JACS’s 10-K, filed March 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about JACS's offering costs charged to additional paid in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JACS's offering costs charged to additional paid in capital?
JACS (JACS) reported offering costs charged to additional paid in capital of $557.74K in Q4 2024.
What does offering costs charged to additional paid in capital mean?
This metric represents the portion of costs directly attributable to the issuance of equity securities that are recorded as a reduction of additional paid-in capital rather than as an expense in the income statement. It reflects the accounting treatment of transaction costs associated with capital raising activities. Investors monitor this to understand the impact of equity issuance costs on the company's total equity base.